Introduction/Overview
Alpha Cyperone (CAS number: 473-08-5) is a natural sesquiterpene compound isolated from the traditional Chinese medicine Cyperus Rotundus L. As one of the main active ingredients of Xiangfu, α - Xiangfu ketone has attracted much attention due to its significant pharmacological activity, especially in the fields of anti-inflammatory, antioxidant, and metabolic regulation, showing potential therapeutic value. In recent years, with the in-depth study of the mechanisms of chronic inflammation related diseases, α - coumarin has shown good anti-inflammatory effects by regulating the expression of inflammation related molecules such as Cox-2, IL-6, and cytoskeletal regulatory proteins Nck-2, Cdc42, and Rac1. In addition, alpha vanillin has shown certain potential in the treatment of metabolic diseases such as hyperglycemia, involving multiple key targets such as EHMT2, AMPK, and SGLT2.
This article provides a systematic review of the chemical structure and physicochemical properties, plant sources, and extraction methods of α - coumarin, with a focus on its pharmacological activity and molecular mechanism of action. Combined with pharmacological evaluation and pharmacokinetic data, it explores its clinical application prospects and development directions, aiming to provide comprehensive and in-depth reference materials for researchers in the field of natural product pharmacology.
Chemical structure and physicochemical properties
Alpha benzophenone is a sesquiterpene ketone compound with a molecular formula of C15H22O and a molecular weight of 218.34. Its structural features include a sesquiterpene skeleton containing a cyclic skeleton and a ketone group, endowing it with certain polarity and reactivity. In terms of physical and chemical properties, the LogP value of α - coumarin is 3.5, indicating that it has moderate lipid solubility and is conducive to penetrating cell membranes and the blood-brain barrier (BBB penetration is high). Its topological polar surface area (TPSA) is 17.07 Å ², and the number of hydrogen bond acceptors is only 1, indicating low molecular polarity, which is beneficial for improving in vivo bioavailability.
In addition, α - Xiangfu ketone has no hepatotoxicity or cardiotoxicity, and does not inhibit hERG channels. The Ames mutagenicity test result is negative, indicating its high safety and good pharmacological basis. These physicochemical and toxicological characteristics lay a solid foundation for its potential as a drug molecule.
Plant sources and extraction methods
Alpha coumarin is mainly present in the volatile oil of Cyperus Rotundus L., a plant of the Cyperus family widely distributed in parts of Asia, Africa, and Europe. It is an important traditional Chinese medicine herb used for regulating qi and blood, relieving pain, and anti-inflammatory effects. The volatile oil of Aconitum carmichaelii is rich in sesquiterpenes, among which α - coumarin has a high content and is one of its main active ingredients.
The common methods for extracting α - coumarin include steam distillation and solvent extraction. The steam distillation method is suitable for extracting the volatile oil of Aconitum carmichaelii, and then purifying it through chromatographic separation techniques such as column chromatography and preparative high-performance liquid chromatography to obtain α - Aconitum carmichaelii ketone. Solvent extraction usually uses ethanol or ethyl acetate as extraction agents, combined with ultrasound assisted extraction or reflux extraction to improve extraction efficiency. During the purification process, high-purity α - coumarin can be obtained using techniques such as silica gel column chromatography and reverse phase HPLC, which facilitates subsequent pharmacological research.
In recent years, with the development of extraction technology, supercritical CO2 extraction technology has also been applied to the extraction of volatile oil from Aconitum carmichaelii, which has the advantages of environmental friendliness and high extraction efficiency, providing new ideas for the industrial production of α - coumarin.
Pharmacological activity research
The pharmacological activity research of α - coumarin mainly focuses on its anti-inflammatory, antioxidant, and metabolic regulatory effects.
anti-inflammatory effect
A large number of in vitro and in vivo experiments have shown that alpha vanillin can significantly inhibit inflammatory reactions. The mechanism involves downregulating the expression of inflammation related enzymes and cytokines, such as cyclooxygenase-2 (Cox-2) and interleukin-6 (IL-6). Cox-2, as a key enzyme involved in the synthesis of inflammatory mediators, reduces its expression and directly decreases the production of prostaglandins, thereby alleviating the inflammatory response. IL-6, as a multifunctional pro-inflammatory cytokine, plays a key role in various inflammatory diseases. Alpha benzophenone inhibits IL-6 expression, regulates immune response, and alleviates inflammatory symptoms.
In addition, α - coumarin also affects the expression of cytoskeleton related proteins Nck-2, Cdc42, and Rac1, which are involved in cell migration, morphological changes, and signal transduction, regulating the activation and chemotaxis of inflammatory cells, and further exerting anti-inflammatory effects.
Antioxidant effect
Oxidative stress is an important mechanism for the occurrence and development of various chronic diseases. Alpha vanillin has the ability to scavenge free radicals, reduce oxidative damage, enhance intracellular antioxidant enzyme activity, alleviate cellular damage caused by oxidative stress, and protect tissue function.
Metabolic regulation effect
In the study of hyperglycemia and related metabolic disorders, alpha vanillin has shown potential in regulating blood sugar and improving metabolic disorders. Although its direct target is not fully understood, relevant studies suggest that it may participate in glucose metabolism, insulin signaling, and energy homeostasis regulation by regulating the expression and function of key proteins such as EHMT2, UBP2, PAI1, AMPK, SGLT2, GCK, APP, BACE1, CES1, and PTPN1.
Among them, AMPK serves as a central regulatory factor in energy metabolism, and activation of the AMPK pathway by α - coumarin can help improve insulin resistance and promote glucose uptake. Inhibition of SGLT2 helps to reduce renal glucose reabsorption and alleviate hyperglycemia.
Mechanism of action and molecular targets
The mechanism of action of α - coumarin is complex and diverse, covering multiple signaling pathways and molecular targets, mainly manifested in the following aspects:
Anti inflammatory mechanism
- Inhibition of Cox-2 expression By blocking the NF - κ B signaling pathway, reducing Cox-2 gene transcription, lowering prostaglandin E2 (PGE2) production, and alleviating inflammatory response.
- Downregulate IL-6 levels Inhibit the release of pro-inflammatory cytokine IL-6, regulate immune cell activity, and alleviate chronic inflammation.
- Regulating cytoskeletal proteins Nck-2, Cdc42, and Rac1 are Rho family small GTPase related proteins involved in cell migration and inflammatory cell activation. Alpha benzophenone inhibits the expression of these proteins, intervenes in the chemotaxis and adhesion processes of inflammatory cells, and reduces the infiltration of inflammatory cells.
Metabolic regulation mechanism
- EHMT2 (Histone Methyltransferase 2)Participate in epigenetic regulation and affect the expression of sugar metabolism related genes. Alpha benzophenone may improve metabolic abnormalities by regulating EHMT2 activity.
- AMPK activation Promote glucose uptake and fatty acid oxidation, improve insulin sensitivity.
- SGLT2 inhibition Reduce renal glucose reabsorption and lower blood sugar levels.
- GCK (glucokinase) regulation Promote glucose metabolism in the liver and pancreas.
- PTPN1 (protein tyrosine phosphatase 1B) inhibition Enhance insulin signaling and improve insulin resistance.
In addition, the regulation of APP and BACE1 by α - coumarin suggests that it may have potential protective effects in neurodegenerative diseases and deserves further research.
Evaluation of drug properties and pharmacokinetics
The pharmacological evaluation of alpha benzophenone shows that it has good potential for drug development:
- Molecular weight 218.34 According to Lipinski's rules, it is beneficial for oral absorption.
- LogP 3.5 Moderate lipid solubility facilitates cell membrane penetration and blood-brain barrier penetration, supporting its potential application in central nervous system diseases.
- TPSA 17.07 Extremely low polarity helps to improve bioavailability.
- Number of hydrogen bond acceptors 1, which contributes to the binding affinity and pharmacokinetic properties between molecules and targets.
- High blood-brain barrier penetration To provide the possibility of treating neurological related diseases.
- Good safety No hepatotoxicity, cardiac toxicity, hERG channel inhibition, Ames test negative, indicating a low risk of toxic side effects.
In terms of pharmacokinetics, although there are few existing literature reports, based on its physicochemical properties, it is speculated that α - coumarin has good oral absorption, wide distribution, and may be enriched in the central nervous system. Its metabolic pathway may involve the liver enzyme system, and excretion is mainly through the kidneys. In the future, systematic ADME (absorption, distribution, metabolism, excretion) research is needed to clarify its in vivo behavior.
Clinical application prospects and prospects
Based on the multi-target regulatory ability and good safety of α - coumarin, its clinical application prospects are broad in various diseases:
- Chronic inflammatory diseases Alpha benzophenone has potential anti-inflammatory therapeutic value by inhibiting inflammatory factors such as Cox-2 and IL-6, such as rheumatoid arthritis and inflammatory bowel disease.
- Metabolic diseases: In the treatment of hyperglycemia and diabetes related complications, α - vanillone is expected to improve blood sugar control and metabolic disorders by regulating AMPK, SGLT2 and other targets.
- Neurodegenerative diseases Regulating the expression of APP and BACE1 suggests that they may play a neuroprotective role in neurodegenerative diseases such as Alzheimer's disease.
- Central nervous system diseases The high blood-brain barrier penetration makes it potential for research in neurological and psychiatric disorders such as depression and anxiety.
Future research should focus on the preclinical pharmacokinetic and toxicological evaluation of alpha benzophenone, conduct systematic in vivo disease model validation, and optimize dosage forms and administration regimens. In addition, based on its multi-target mechanism of action and combined with modern drug design techniques, the development of α - benzophenone derivatives or combination therapy strategies will help enhance its clinical translational value.
Conclusion
As a natural sesquiterpene ketone derived from traditional Chinese medicine Xiangfu, α - Xiangfu ketone has become an important research object in the field of natural product pharmacology due to its significant anti-inflammatory and metabolic regulatory activities, as well as good medicinal properties. It exhibits broad pharmacological potential and clinical application prospects by regulating inflammation and metabolism related molecules through multiple targets and pathways. In the future, by combining modern pharmacology and medicinal chemistry techniques, the mechanism of action and in vivo behavior of α - coumarin will be further elucidated, providing a solid foundation for its development into a new natural medicine and promoting its application in the treatment of chronic inflammation and metabolic diseases.